Literature DB >> 20173387

Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology.

Panagiota Stamou1, Dimitris L Kontoyiannis.   

Abstract

The relationship between TNF and immune pathology forced an intense research into the regulation of its biosynthesis that extends to multiple mechanisms controlling the utilization of its mRNA. These posttranscriptional mechanisms gradually and variably impose a series of flexible rate-limiting controls to modify the abundance of the TNF mRNA and the rate of its translation in response to environmental signals. Mechanistically, these controls consist of signaling networks converging to RNA-binding proteins and microRNAs, which in turn target a code of secondary or tertiary ribonucleotide structures located on the TNF mRNA. The outcome of these interactions is the stringent control of this mRNA's maturation, localization, turnover and translation. A wealth of molecular and genetic data highlighted that if these posttranscriptional interactions fail, they perturb cellular responses to provide the impetus for TNF-mediated inflammatory disease. Here, we highlight the parameters guiding the posttranscriptional regulation of TNF mRNA and their relevance to homeostasis and pathology. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173387     DOI: 10.1159/000289197

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  22 in total

Review 1.  Systems biology in immunology: a computational modeling perspective.

Authors:  Ronald N Germain; Martin Meier-Schellersheim; Aleksandra Nita-Lazar; Iain D C Fraser
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

2.  Design, synthesis and biological assessment of novel N-substituted 3-(phthalimidin-2-yl)-2,6-dioxopiperidines and 3-substituted 2,6-dioxopiperidines for TNF-α inhibitory activity.

Authors:  Weiming Luo; Qian-sheng Yu; Isidro Salcedo; Harold W Holloway; Debomoy K Lahiri; Arnold Brossi; David Tweedie; Nigel H Greig
Journal:  Bioorg Med Chem       Date:  2011-05-23       Impact factor: 3.641

Review 3.  The complex world of post-transcriptional mechanisms: is their deregulation a common link for diseases? Focus on ELAV-like RNA-binding proteins.

Authors:  Alessia Pascale; Stefano Govoni
Journal:  Cell Mol Life Sci       Date:  2011-09-10       Impact factor: 9.261

Review 4.  miRNA in wound inflammation and angiogenesis.

Authors:  Sashwati Roy; Chandan K Sen
Journal:  Microcirculation       Date:  2012-04       Impact factor: 2.628

5.  Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis.

Authors:  Michelle A Erickson; William A Banks
Journal:  Brain Behav Immun       Date:  2011-06-17       Impact factor: 7.217

6.  Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice.

Authors:  Renana Baratz; David Tweedie; Vardit Rubovitch; Weiming Luo; Jeong Seon Yoon; Barry J Hoffer; Nigel H Greig; Chaim G Pick
Journal:  J Neurochem       Date:  2011-08-05       Impact factor: 5.372

Review 7.  MiRNA in innate immune responses: novel players in wound inflammation.

Authors:  Sashwati Roy; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-12-07       Impact factor: 3.107

8.  The Emerging Field of Human Social Genomics.

Authors:  George M Slavich; Steven W Cole
Journal:  Clin Psychol Sci       Date:  2013-07

9.  Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Diane E Griffin
Journal:  J Gen Virol       Date:  2016-09-22       Impact factor: 3.891

10.  Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor-α translation through a SHIP1-dependent pathway.

Authors:  Catherine S Chan; Andrew Ming-Lum; Gary B Golds; Shaina J Lee; Raymond J Anderson; Alice L-F Mui
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.